Literature DB >> 9192666

Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.

J G Flannery1, S Zolotukhin, M I Vaquero, M M LaVail, N Muzyczka, W W Hauswirth.   

Abstract

We describe a general approach for achieving efficient and cell type-specific expression of exogenous genes in photoreceptor cells of the mammalian retina. Recombinant adeno-associated virus (rAAV) vectors were used to transfer the bacterial lacZ gene or a synthetic green fluorescent protein gene (gfp) to mouse or rat retinas after injection into the subretinal space. Using a proximal murine rod opsin promoter (+86 to -385) to drive expression, reporter gene product was found exclusively in photoreceptors, not in any other retinal cell type or in the adjacent retinal pigment epithelium. GFP-expressing photoreceptors typically encompassed 10-20% of the total retinal area after a single 2-microl injection. Photoreceptors were transduced with nearly 100% efficiency in the region directly surrounding the injection site. We estimate approximately 2.5 million photoreceptors were transduced as a result of the single subretinal inoculation. This level of gene transfer and expression suggests the feasibility of genetic therapy for retinal disease. The gfp-containing rAAV stock was substantially free of both adenovirus and wild-type AAV, as judged by plaque assay and infectious center assay, respectively. Thus, highly purified, helper virus-free rAAV vectors can achieve high-frequency tissue-specific transduction of terminally differentiated, postmitotic photoreceptor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192666      PMCID: PMC21259          DOI: 10.1073/pnas.94.13.6916

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  In vivo adenovirus-mediated gene transfer into ocular tissues.

Authors:  B Mashhour; D Couton; M Perricaudet; P Briand
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

2.  In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector.

Authors:  T Li; M Adamian; D J Roof; E L Berson; T P Dryja; B J Roessler; B L Davidson
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-04       Impact factor: 4.799

3.  Developmentally important DNA elements within the bovine opsin upstream region.

Authors:  L E DesJardin; W W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-01       Impact factor: 4.799

4.  Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

Authors:  P D Kessler; G M Podsakoff; X Chen; S A McQuiston; P C Colosi; L A Matelis; G J Kurtzman; B J Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Mutations in the gene encoding the alpha subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa.

Authors:  T P Dryja; J T Finn; Y W Peng; T L McGee; E L Berson; K W Yau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis.

Authors:  K J Fisher; G P Gao; M D Weitzman; R DeMatteo; J F Burda; J M Wilson
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.

Authors:  M G Kaplitt; P Leone; R J Samulski; X Xiao; D W Pfaff; K L O'Malley; M J During
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

Review 8.  Survival factors in retinal degenerations.

Authors:  R H Steinberg
Journal:  Curr Opin Neurobiol       Date:  1994-08       Impact factor: 6.627

Review 9.  Retinal photoreceptor dystrophies LI. Edward Jackson Memorial Lecture.

Authors:  A C Bird
Journal:  Am J Ophthalmol       Date:  1995-05       Impact factor: 5.258

10.  DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.

Authors:  D W Russell; I E Alexander; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  101 in total

1.  Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

Authors:  J Bennett; A M Maguire; A V Cideciyan; M Schnell; E Glover; V Anand; T S Aleman; N Chirmule; A R Gupta; Y Huang; G P Gao; W C Nyberg; J Tazelaar; J Hughes; J M Wilson; S G Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

3.  Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

Authors:  M M LaVail; D Yasumura; M T Matthes; K A Drenser; J G Flannery; A S Lewin; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 4.  The Gordon Wilson Lecture. From basic virology to human gene therapy.

Authors:  K I Berns
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

5.  Viral-mediated FGF-2 treatment of the constant light damage model of photoreceptor degeneration.

Authors:  Dana Lau; John Flannery
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

6.  Genetic fate of recombinant adeno-associated virus vector genomes in muscle.

Authors:  Bruce C Schnepp; K Reed Clark; Dori L Klemanski; Christina A Pacak; Philip R Johnson
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 7.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

8.  Marking cells with infrared fluorescent proteins to preserve photoresponsiveness in the retina.

Authors:  Bozena Fyk-Kolodziej; Chase B Hellmer; Tomomi Ichinose
Journal:  Biotechniques       Date:  2014-11-01       Impact factor: 1.993

Review 9.  Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges.

Authors:  Deepak Raj; Andrew M Davidoff; Amit C Nathwani
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

10.  Gene transfer for the treatment of neovascular ocular disease (an American Ophthalmological Society thesis).

Authors:  John Timothy Stout
Journal:  Trans Am Ophthalmol Soc       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.